Perfection in the staging of thymic epithelial tumours: is it always obligatory?

The choice of the optimal treatment of thymic epithelial tumours (TETs) is an important and widely discussed issue, especially in patients with advanced tumours. In recent years, clinical stage III thymomas have usually been managed with neoadjuvant therapy and subsequent radical surgery [1–3]. The role of operative treatment with adjuvant chemotherapy in stage IV thymomas is more controversial, with a growing number of reports supporting such a...